A researcher from The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has received a joint appointment as the leader of a new initiative of CSIRO.
New research findings from The University of Queensland have revealed that hollow nanospheres made from iron oxide hold promise as an antibacterial agent to fight diseases caused by microbial infections.
Researchers at The University of Queensland are developing a vaccine to reduce the staggering level of infant mortality from rotavirus in developing countries by significantly decreasing the cost of vaccine production and logistics.
Queensland’s peak industry body for women in technology and life sciences has recognised the outstanding early career achievements of a young researcher from The University of Queensland.
Recent clinical trials of a new method for delivering non-steroidal anti-inflammatory drugs (NSAIDs) using clay nanoparticles developed by researchers at The University of Queensland have shown positive results.